An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · May 16, 2024
Trial Information
Current as of February 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying head and neck cancer, specifically looking at the cells and markers that are linked to how aggressive the cancer can be. Researchers want to understand why some cancers behave more aggressively than others, which can help in finding better treatments and ways to manage the disease.
To participate in this trial, you must be at least 18 years old and have recently been diagnosed with head and neck cancer without having received any prior treatment. If you join the study, you'll provide important information that could lead to new insights about this type of cancer. It's also important to remember that the study is currently recruiting participants, so there's an opportunity for eligible individuals to contribute to this important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis/disease status: New diagnosis of head and neck cancer
- • Allowable type and amount of prior therapy: No prior treatment
- • Age ≥ 18 years.
- • Ability to understand and the willingness to sign a written informed consent.
- Exclusion Criteria:
- • Patients who have had treatment of head and neck cancer
Trial Officials
Albert Y Han, MD
Principal Investigator
University of Southern California
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0